A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer.

Igor TsaurIsabel HeideggerJasmin BekticMona KafkaRoderick C N van den BerghJarmo C B HuntingAnita ThomasMaximilian P BrandtThomas HöfnerEliott DebeddeConstance ThibaultPaola ErmacoraFabio ZattoniSilvia FotiAlexander KretschmerGuillaume PloussardSeverin RodlerGunhild von AmsbergDerya TilkiChristian SurcelBarak RosenzweigMoran GadotGiorgio GandagliaRobert Dotzauernull null

Published in: Cancer medicine (2021)

AA+ADT is mainly associated with a similar efficacy and overall toxicity rate as D+ADT. Further prospective research is required for validation of the clinical value of the observed benefit of AA+ADT for progression-free end-points.

Keyphrases

prostate cancer
squamous cell carcinoma
radical prostatectomy
small cell lung cancer
radiation therapy
clinical evaluation